Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1 Meningioma 1 Ependymoma 1

Interventions

Magnetic Resonance Spectroscopy 4 Specimen Handling 3 lutetium Lu 177 dotatate 2 Bevacizumab 2 regorafenib 1 olaparib 1 neratinib 1 gallium Ga 68 dotatate 1 capivasertib 1 cabozantinib 1 brigatinib 1 abemaciclib 1 Watchful Waiting 1 Tablets 1 Surveys and Questionnaires 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Protons 1 Proton Therapy 1 Observation 1 Nivolumab 1 Lysine 1 Ipilimumab 1 Hydroxyurea 1 HhAntag691 1 Ga(III)-DOTATOC 1 GSK2256098 1 Everolimus 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × brigatinib × 30 days × Clear all

NCT04374305 2026-05-06

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡